China medical device registration timeline
Source-linked clocksNational Medical Products Administration (NMPA) review clocks and end-to-end planning ranges, using the 3-class (I, II, III) classification system.
| Class / pathway | Review clock | Planning total | With prior approval | Provenance |
|---|---|---|---|---|
| Class I(Filing/Recordation (备案) — no review, no fee) Zero days is the published position, not an estimate: the NMPA service item classifies the filing as an 即办件 and states that where the materials are complete and in the required form the filing is made 当场 — on the spot — against a sealed 备案凭证 | 0 days | 2-4 months | — | Verified |
| Class II(Provincial Registration) Technical review 60 days under the parallel Order No. 47 Art. 92 structure; statutory administrative decision 20 working days; promised acceptance 5 working days | 4 months | 1-1.5 years | — | Verified |
| Class III(NMPA Registration) Class III technical review: 90 days for registration/change/renewal, 60 days after applicant supplement (Order No. 47 Art. 92); statutory administrative decision 20 working days; promised acceptance 5 working days | 5-6 months | 2-3 years | 1.2-1.7 years | Verified |
Planning steps and estimates; these are not regulator deadlines.
China Medical Device Registration Process
Step-by-step NMPA registration process. Total estimated timeline: 2-4 months.
Step 1: Device Classification
2-4 weeksClassify device under NMPA rules (Class I, II, or III). Class III requires full registration.
Step 2: In-Country Testing
3-6 monthsTesting at NMPA-designated Chinese laboratories required for most Class II/III devices.
Step 3: Clinical Trial (if required)
12-24 monthsMany Class II/III devices require Chinese clinical trials. Can take 12-24 months.
Step 4: Appoint Agent
2-4 weeksForeign manufacturers must appoint a Chinese agent/legal representative for submissions.
Step 5: NMPA Application
1-2 weeksSubmit registration dossier to NMPA/CFDA. Documentation must be in Chinese.
Step 6: NMPA Review
12-18 monthsNMPA conducts technical review. Multiple Q&A rounds common. Average 12-18 months for Class III.
Step 7: Registration Certificate
2-4 weeksNMPA issues registration certificate. Valid 5 years with annual renewal requirements.
Expedited review for rare diseases, malignant tumors, pediatric devices
Eligibility: Significant clinical advantage, No alternative treatment, Innovative technology
Fast-track initial use with real-world data collection
Eligibility: Approved overseas (FDA, CE), Not yet registered in China nationally
Fast-track for Hong Kong/Macau approved devices
Eligibility: Hong Kong or Macau approval
- China Agent (mandatory for foreign manufacturers)
- In-country testing at NMPA-certified lab
- Chinese labeling and IFU
- Clinical trial (Class III, unless exempted)
- GMP compliance (Class II & III)
- Clinical-trial approval review: 60 days for the trial application, 40 days after supplement (Order No. 47 Art. 92)
- The registration clock is built from four published segments, which is why the class figures are sums rather than single periods: 5 working days promised for acceptance, 3 working days to transfer the file to the technical review centre, the Order No. 47 Art. 92 technical review, then 20 working days under Regulation No. 739 art. 18 for the administrative decision
- Two exclusions sit outside the review clock: the applicant has one year to complete a supplement request, and the 15-day objection window against a proposed negative opinion under Order No. 47 Art. 57 is expressly not counted
- Approved registrations are published within 5 working days (Regulation No. 739 art. 18), and Class I filings within 5 working days of receipt (art. 15)
Reviewed 2026-08-30. End-to-end totals remain planning estimates.